HopeStage
Back to all studies
CompletedNCT00556140

Aripiprazole added to antidepressants for psychotic depression

About this titleRead the official source — NCT00556140

Researchers studied Aripiprazole, tracking side effects to assess safety and tolerability in people with depression.

Medication studyAges 18–80United States
The study in practice

Understand this study

What did researchers investigate?

Researchers studied Aripiprazole, tracking side effects to assess safety and tolerability in people with depression.

Who was this study for?

Listed age limits: 18 years to 80 years.

What did participation involve?

The study group receives aripiprazole as a study medication.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2003
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT00556140
Official title
Show the full official title

The Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in the Acute Treatment of Psychotic Major Depression: Efficacy and Tolerability

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers studied Aripiprazole, tracking side effects to assess safety and tolerability in people with depression.

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole.

Who was this study for?

Listed age limits: 18 years to 80 years.

Want to explore more studies?

Explore studies